Tikosyn
NDC 69189-5800
Product Information
Tikosyn is a NDA-approved product labeled by Avera Mckennan Hospital. This medication is used to treat certain types of serious (possibly fatal) irregular heartbeat (such as atrial fibrillation/flutter). It is supplied as a orange product. This product entry covers the primary NDC 69189-5800 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
WHITE (C48325)
TKN;125;PFIZER
Code Structure Chart
Product Details
What is NDC 69189-5800?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- DOFETILIDE (UNII: R4Z9X1N2ND)
- DOFETILIDE (UNII: R4Z9X1N2ND) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- STARCH, CORN (UNII: O8232NY3SJ)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 284404 - Tikosyn 125 MCG Oral Capsule
- RxCUI: 284404 - dofetilide 0.125 MG Oral Capsule [Tikosyn]
- RxCUI: 284404 - Tikosyn 0.125 MG Oral Capsule
- RxCUI: 310003 - dofetilide 125 MCG Oral Capsule
- RxCUI: 310003 - dofetilide 0.125 MG Oral Capsule
* Please review the full disclaimer at the bottom of this page.